Setria Glutathione approved for use in Australia

25-Nov-2014 - Last updated on 25-Nov-2014 at 10:36 GMT

Often called the “master antioxidant”, glutathione is a tripeptide present in nearly all body cells

Australia’s Therapeutics Goods Administration has approved Setria Glutathione for use as a “therapeutically active ingredient in adults”.

Kyowa Hakko’s Setria Glutathione will be exclusivity distributed in Australia by Trans Chem, a biotech specialist that sources and imports chemicals to Australian manufacturers.

TGA approval of Setria Glutathione was received in October, after a milestone clinical trial of the master antioxidant showed positive results, which were published in the European Journal of Nutrition.

Setria meets the current United States pharmacopeial convention standards and is available as a dietary supplement in the United States, Canada, Mexico,and select countries in Europe and Asia.

Glutathione is a natural antioxidant that is obtained from food and as part of the body’s internal production. For many reasons, including age, health conditions, lifestyle, environment and certain medications, the body’s stores of glutathione may be in shorty supply.

Kyowa Hakko uses a patented fermentation technology to manufacture a pure form of Setria Glutathione. It replenishes the body’s stores, helping to protect cells from oxidative stress and harmful toxins associated with free radicals.